Over his career, Warren Buffett established himself as one of the world's best investors. However, after 60 years at ...

At its current pace, the software giant could spend it all before 2030. What might that do to earnings per share?

Novo Nordisk covers its dividend, and Pfizer doesn't, but investors appear increasingly worried about Novo's future.

And this spring, Lilly won regulatory approval for Foundayo. All three are part of a class of drugs known as GLP-1. These ...

Zepbound was a breakthrough. It became the first medicine to mimic the GLP-1 and GIP gut hormones and be approved for weight ...

Since 1945, the U.S. stock market has endured 37 corrections (declines of 10% or more), according to data from MUFG. These 10 ...

Memory chip stocks had a great 2026. 2027 could be another incredible year.

By the time the Fed raised rates on Sept. 21, 2022, the S&P 500 was already 21% below its January 2022 record high, as the ...

With a forward price-to-earnings (P/E) ratio of 6.5 times fiscal 2027 analyst estimates, Micron's stock looks dirt cheap. The ...

With around half of the United States' watch hours going to streaming today, and even less in some international markets, ...

The more important figure is the running total. Through three quarters, Tesla has delivered 1,324,681 vehicles, around 9% ...

Beyond defense, BWXT draws on decades of expertise in nuclear components and is well-positioned to capitalize on surging ...